Synthesis and X-ray diffraction data of 2-ethyl-6-(pyridin-4-yl)-7H-indeno [2,1-c]quinoline

Vista sencilla de ítem
dc.contributor.authorCamargo, H.A.
dc.contributor.authorSánchez, A.
dc.contributor.authorHenao, J.A.
dc.contributor.authorRomero Bohórquez, Arnold R.
dc.contributor.authorKouznetsov, Vladimir V.
dc.date.accessioned2020-01-17T15:38:18Z
dc.date.available2020-01-17T15:38:18Z
dc.date.issued2014-03
dc.description.abstractThe compound 2-ethyl-6-(pyridin-4-yl)-7H-indeno[2,1-c]quinoline (2) (chemical formula C23H22N2) was synthesized through the free-solvent oxidation reaction mediated by elemental sulfur from the corresponding 2-ethyl-6-(pyridin-4-yl)-5,6,6a,11b-tetrahidro-7H-indeno[2,1-c]quinoline (1), an adduct easily obtained, using the Lewis acid-promoted [4 + 2] cycloaddition reaction. Preliminary molecular characterization was performed by Fourier transform-infrared and gas chromatographymass spectrometry. The X-ray powder diffraction (XRPD) pattern for the title compound was analyzed and found to be crystallized in monoclinic system, space group P21/n (N° 14) with refined unit-cell parameters a = 20.795 (8) Å, b = 7.484 (2) Å, c = 10.787 (2) Å and ß = 93.96° (2). The volume of the unit cell is V = 1674.8 (6) Å3 .spa
dc.description.domainhttp://unidadinvestigacion.usta.edu.cospa
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1017/S0885715613000730spa
dc.identifier.urihttp://hdl.handle.net/11634/20710
dc.publisher.branchCRAI-USTA Bogotáspa
dc.relation.referencesBoultif, A. and Loüer, D. (2004). “Indexing of powder diffraction patterns of low symmetry lattices by successive dichotomy method,” J. Appl. Crystallogr. 37, 724–731spa
dc.relation.referencesde Wolff, P. M. (1968). “A simplified criterion for the reliability of a powder pattern,” J. Appl. Crystallogr. 1, 108–113.spa
dc.relation.referencesDong, C. (1999). “PowderX: Windows-95-based program for powder X-ray diffraction data processing,” J. Appl. Crystallogr. 32, 838–838.spa
dc.relation.referencesEwesuedo, R. B., Iyer, L., Das, S., Koenig, A., Mani, S., Vogelzang, N. J., Schilsky, R. L., Brenckman, W., and Ratain, M. J. (2001). “Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer,” J. Clin. Oncol. 19, 2084–2090.spa
dc.relation.referencesGelderblom, H. and Sparreboom, A. (2006). “Topoisomerase inhibitors.” Drugs Affecting of Tumours, edited by H. M. Pinedo and C. H. Smorenburg (Birkhuser Vergal, Switzerland), pp. 83–100.spa
dc.relation.referencesIshida, K. and Asao, T. (2002). “Self-association and unique DNA binding properties of the anti-cancer agent TAS-103, a dual inhibitor of topoisomerases I and II,” Biochim. Biophys. Acta 1587, 155–163.spa
dc.relation.referencesKouznetsov, V. V., Ochoa Puentes, C., Romero Bohorquez, A. R., Zacchino, S., Sortino, M., Gupta, M., Vásquez, Y., and Bahsas, A. (2006). “A straightforward synthetic approach to antitumoral pyridinyl substituted 7H-Indeno[2,1-c]quinoline derivatives via three-component imino Diels-Alder reaction,” Lett.Org. Chem. 3, 300–304.spa
dc.relation.referencesKouznetsov, V. V., Romero Bohórquez, A. R., and Astudillo, L. (2009). “A convenient procedure for the synthesis of new α-Pyridinyl-substituted 7H-Indeno[2,1-c]quinoline derivatives based on a three-component imino Diels–Alder reaction,” Synthesis 24, 4219–4225.spa
dc.relation.referencesLaugier, J. and Bochu, B. (2002). CHEKCELL. “LMGP-Suite–Suite of Programs for the interpretation of X-ray. Experiments,” ENSP/ Laboratoire des Matériaux et du Génie Physique, BP 46. 38042, Saint Martin d’Hères, France. http://www.inpg.fr/LMGP and http://www. ccp14.ac.uk/tutorial/lmgp/.spa
dc.relation.referencesLi, Q. -Y., Zu, Y. -G., Shi, R. -Z., and Yao, L. -P. (2006). “Review camptothecin: current perspectives,” Curr. Med. Chem. 13, 2021–2039.spa
dc.relation.referencesMiguell, A. D., Hubberd, C. R., and Stalick, J. K. (1981). NBS* AIDS80: A FORTRAN Program for Crystallographic Data Evaluation. Tech. Note 1141. USA: National Bureau of Standards.spa
dc.relation.referencesOhyama, T., Li, Y., Utsugi, T., Irie, S., Yamada, Y., and Sato, T. (1999). “A dual topoisomerase inhibitor, TAS-103, induces apoptosis in human cancer cells,” Jpn J. Cancer Res. 90, 691–698.spa
dc.relation.referencesPommier, Y. (2006). “Topoisomerase I inhibitors: camptothecins and beyond,” Nat. Rev. Cancer. 6, 789–802.spa
dc.relation.referencesPriel, E., Showalter, S. D., Roberts, M., Oroszlan, S., and Blair, D. G. (1991). “The topoisomerase I inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2Th cells,” J. Virol. 65, 4137–4141.spa
dc.relation.referencesRachinger, W. A. (1948). “A correction for the α1 α2 doublet in the measurement of widths of X-ray diffraction lines,” J. Sci. Instrum. 25, 254.spa
dc.relation.referencesSaviztky, A. and Golay, M. J. (1964). “Smoothing and differentiation of data by simplified least squares procedures,” Anal. Chem. 36, 1627–1639.spa
dc.relation.referencesSmith, G. S. and Snyder, R. L. (1979). “FN: a criterion for rating powder diffraction patterns and evaluating the reliability of powder-pattern indexing,” J. Appl. Crystallogr. 12, 60–65.spa
dc.relation.referencesSonneveld, E. J. and Visser, J. W. (1975). “Automatic collection of powder diffraction data from photographs,” J. Appl. Crystallogr. 8, 1–7.spa
dc.relation.referencesTwelves, C. J., Gardner, C., Flavin, A., Sludden, J., Dennis, I., de Bono, J., Beale, P., Vasey, P., Hutchison, C., Macham, M. A., Rodríguez, A., Judson, I., and Bleehen, N. M. (1999). “Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II,” Br. J. Cancer 80, 1786–1791.spa
dc.rightsAtribución-NoComercial-CompartirIgual 2.5 Colombia
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/2.5/co/
dc.subject.keywordindeno[2, 1-c]quinolinesspa
dc.subject.keywordAntitumoral activityspa
dc.subject.keywordX-ray powder diffractionspa
dc.titleSynthesis and X-ray diffraction data of 2-ethyl-6-(pyridin-4-yl)-7H-indeno [2,1-c]quinolinespa
dc.type.categoryGeneración de Nuevo Conocimiento: Artículos publicados en revistas especializadas - Electrónicosspa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
Synthesis and X-ray diffraction data of 2-ethyl-6-(pyridin-4-yl)-7H-indeno [2,1-c]quinoline.pdf
Tamaño:
125.91 KB
Formato:
Adobe Portable Document Format
Descripción:
Artículo SCOPUS
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
807 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Producción de Alto Impacto